November 12, 2019
FDA Approves Test for Late-line HRD+ Ovarian Cancer BookmarkGeorge Lundberg, MD
Article from Cancer Network curated by Editor in Chief George Lundberg, MD, who notes:
A new diagnostic test and new therapeutic drugs have received approval from the U.S. Food and Drug Administration (FDA) for certain advanced ovarian cancers, which are always difficult to treat.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.